Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Bainter TM"'
Autor:
Van Blarigan EL; University of California, San Francisco, San Francisco, California, USA., Ma C; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ou FS; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota, USA., Bainter TM; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota, USA., Venook AP; University of California, San Francisco, San Francisco, California, USA., Ng K; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Niedzwiecki D; Duke Cancer Institute, Duke University, Durham, North Carolina, USA., Giovannucci E; Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA., Lenz HJ; University of Southern California Norris Comprehensive Cancer Center, Los Angeles, California, USA., Polite BN; University of Chicago Comprehensive Cancer Center, Chicago, Illinois, USA., Hochster HS; Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey, USA., Goldberg RM; West Virginia University Cancer Institute, Morgantown, West Virginia, USA., Mayer RJ; Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Blanke CD; SWOG Group Chair's Office, Oregon Health & Science University, Knight Cancer Institute, Portland, Oregon, USA., O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, New York, USA., Ciombor KK; Vanderbilt-Ingram Cancer Center, Nashville, Tennessee, USA., Meyerhardt JA; Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 Jan 15; Vol. 152 (2), pp. 123-136. Date of Electronic Publication: 2022 Aug 20.
Autor:
Ji H; Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota, USA., Barr Fritcher EG; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Yin J; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA., Bainter TM; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA., Zemla TJ; Department of Health Sciences Research, Mayo Clinic, Rochester, Minnesota, USA., Gores GJ; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA., Halling KC; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Kipp BR; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA., Roberts LR; Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA.
Publikováno v:
Clinical and translational gastroenterology [Clin Transl Gastroenterol] 2022 Oct 01; Vol. 13 (10), pp. e00523. Date of Electronic Publication: 2022 Oct 01.
Autor:
Lee S; Yale School of Medicine, New Haven, CT, USA., Ma C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Zhang S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ou FS; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., Bainter TM; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, USA., Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke University, Durham, NC, USA., Saltz LB; Memorial Sloan Kettering Cancer Center, New York, NY, USA., Mayer RJ; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA, USA., Whittom R; Hôpital du Sacré-Coeur de Montréal, Montreal, Canada., Hantel A; Loyola University Stritch School of Medicine, Naperville, IL, USA., Benson A; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL, USA., Atienza D; Virginia Oncology Associates, Norfolk, VA, USA., Kindler H; University of Chicago Comprehensive Cancer Center, Chicago, IL, USA., Gross CP; Yale School of Medicine, Department of Internal Medicine, New Haven, CT, USA., Irwin ML; Yale School of Public Health, New Haven, CT, USA., Meyerhardt JA; Department of Medical Oncology, Dana-Farber/Partners CancerCare, Boston, MA, USA., Fuchs CS; Yale Cancer Center, Smilow Cancer Hospital and Yale School of Medicine, New Haven, CT, USA.; Genentech, South San Francisco, CA, USA.
Publikováno v:
The oncologist [Oncologist] 2022 Jun 08; Vol. 27 (6), pp. e494-e505.
Autor:
McCleary NJ; Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America. Electronic address: nj_mccleary@dfci.harvard.edu., Zhang S; Dana-Farber Cancer Institute, Boston, MA, United States of America., Ma C; Dana-Farber Cancer Institute, Boston, MA, United States of America., Ou FS; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, United States of America., Bainter TM; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN, United States of America., Venook AP; University of California, San Francisco, CA., Niedzwiecki D; Duke University, Durham, NC, United States of America., Lenz HJ; USC Norris Comprehensive Cancer Center, Los Angeles, CA, United States of America., Innocenti F; The University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America., O'Neil BH; Simon Cancer Center, Indiana University School of Medicine, Indianapolis, IN, United States of America., Polite BN; Pritzker School of Medicine, The University of Chicago, Chicago, IL, United States of America., Hochster HS; Department of Medical Oncology, Rutgers Cancer Institute of New Jersey, Brunswick, NJ, United States of America., Atkins JN; Southeast Cancer Control Consortium, CCOP, Goldsboro, NC, United States of America., Goldberg RM; West Virginia University Cancer Institute, Morgantown, WV, United States of America., Ng K; Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America., Mayer RJ; Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America., Blanke CD; SWOG and Oregon Health & Science University, Portland, OR, United States of America., O'Reilly EM; Memorial Sloan-Kettering Cancer Center, New York, NY, United States of America., Fuchs CS; Yale Cancer Center and Smillow Cancer Hospital, Yale School of Medicine, New Haven, CT, United States of America., Meyerhardt JA; Dana-Farber Cancer Institute, Boston, MA, United States of America; Harvard Medical School, Boston, MA, United States of America.
Publikováno v:
Journal of geriatric oncology [J Geriatr Oncol] 2022 May; Vol. 13 (4), pp. 469-479. Date of Electronic Publication: 2022 Jan 31.
Autor:
Lipsyc-Sharf M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Zhang S; Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA., Ou FS; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA., Ma C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McCleary NJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke Cancer Institute, Duke University, Durham, NC, USA., Chang IW; Southeast Clinical Oncology Research (SCOR) Consortium, Winston-Salem, NC, USA., Lenz HJ; Division of Medical Oncology, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA., Blanke CD; SWOG Group Chair's Office/Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Piawah S; Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Van Loon K; Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Bainter TM; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA., Venook AP; Department of Medicine, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Fuchs CS; Yale Cancer Center and Smilow Cancer Hospital, New Haven, CT, USA.; Genentech, South San Francisco, CA, USA., Innocenti F; Eshelman School of Pharmacy and Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Nixon AB; Duke Cancer Institute, Duke University, Durham, NC, USA., Goldberg R; West Virginia University Cancer Institute, Morgantown, WV, USA., O'Reilly EM; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Publikováno v:
Journal of the National Cancer Institute [J Natl Cancer Inst] 2022 Mar 08; Vol. 114 (3), pp. 427-435.
Autor:
Cheng E; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.; Division of Research, Kaiser Permanente Northern California, Oakland, CA., Ou FS; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN., Ma C; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Spiegelman D; Department of Biostatistics, Yale School of Public Health, New Haven, CT.; Center on Methods for Implementation and Prevention Science, Yale School of Public Health, New Haven, CT., Zhang S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Zhou X; Department of Biostatistics, Yale School of Public Health, New Haven, CT.; Center on Methods for Implementation and Prevention Science, Yale School of Public Health, New Haven, CT., Bainter TM; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, MN., Saltz LB; Memorial Sloan Kettering Cancer Center, New York, NY., Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke University Medical Center, Durham, NC., Mayer RJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Whittom R; Hôpital du Sacré-Coeur de Montréal, Montreal, Quebec, Canada., Hantel A; Loyola University, Stritch School of Medicine, Naperville, IL., Benson A; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL., Atienza D; Virginia Oncology Associates, Norfolk, VA., Messino M; Messino Cancer Centers, Asheville, NC., Kindler H; University of Chicago, Chicago, IL., Giovannucci EL; Department of Epidemiology, and Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA., Van Blarigan EL; Department of Epidemiology and Biostatistics, and Urology, University of California, San Francisco, CA., Brown JC; Cancer Metabolism Program, Pennington Biomedical Research Center, Baton Rouge, LA., Ng K; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Gross CP; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.; Section of General Internal Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Cancer Outcomes, Public Policy, and Effectiveness Research Center, Yale Cancer Center, New Haven, CT., Meyerhardt JA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA., Fuchs CS; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT.; Division of Hematology and Medical Oncology, Department of Internal Medicine, Yale School of Medicine, New Haven, CT.; Yale Cancer Center, Smilow Cancer Hospital, New Haven, CT.; Hematology and Oncology Product Development, Genentech & Roche, South San Francisco, CA.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2022 Mar 01; Vol. 40 (7), pp. 740-751. Date of Electronic Publication: 2022 Jan 07.
Autor:
Van Blarigan EL; Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco.; Department of Urology, University of California at San Francisco, San Francisco., Ou FS; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Bainter TM; Alliance Statistics and Data Management Center, Mayo Clinic, Rochester, Minnesota., Fuchs CS; Yale Cancer Center, Yale School of Medicine, New Haven, Connecticut., Niedzwiecki D; Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, North Carolina., Zhang S; Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland., Saltz LB; Memorial Sloan Kettering Cancer Center, New York, New York., Mayer RJ; Dana-Farber Cancer Institute, Boston, Massachusetts., Hantel A; Edward Hematology Oncology Group, Naperville, Illinois., Benson AB 3rd; Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois., Atienza D; Virginia Oncology Associates, Norfolk., Messino M; Southeast Clinical Oncology Research Consortium, Mission Hospitals, Inc, Asheville, North Carolina., Kindler HL; University of Chicago Comprehensive Cancer Center, Chicago, Illinois., Venook AP; Helen Diller Family Comprehensive Cancer Center, San Francisco, California.; Division of Hematology/Oncology, Department of Medicine, University of California at San Francisco, San Francisco., Ogino S; Program in Molecular Pathology Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge., Sanoff HK; University of North Carolina Lineberger Comprehensive Cancer Center, Chapel Hill., Giovannucci EL; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.; Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, Massachusetts., Ng K; Dana-Farber Cancer Institute, Boston, Massachusetts., Meyerhardt JA; Dana-Farber Cancer Institute, Boston, Massachusetts.
Publikováno v:
JAMA network open [JAMA Netw Open] 2022 Feb 01; Vol. 5 (2), pp. e220145. Date of Electronic Publication: 2022 Feb 01.